Detalhe da pesquisa
1.
Two-year follow-up of the NEVO ResElution-I(NEVO RES-I)trial: a randomised, multicentre comparison of the NEVOsirolimus-eluting coronary stent with the TAXUS Libertépaclitaxel-eluting stent in de novo native coronary arterylesions
EuroIntervention;
09: 721-729, 2013. ilus
Artigo
em Inglês
| SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1062680
2.
Intravascular ultrasound results from the NEVO ResElution-I trial: a randomized, blinded comparison of sirolimus-eluting NEVO stentswith paclitaxel-eluting TAXUS Liberté stents in de novo native coronaryartery lesions
Circ Cardiovasc Interv;
4(2): 146-154, 2011. ilus, tab
Artigo
em Inglês
| SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1061963